Urological and oncological expertise
With proven and new preparations against cancer.
JEmedis has many years of experience and expertise in the field of oncology.
The distribution of our chemotherapeutic agent for the treatment of
bladder carcinomas and the development of a further preparation for this indication, which we are currently working on.
JEmedis. Against cancer.
Bladder carcinoma is the fifth most common malignant tumor disease in humans. The risk of men developing bladder cancer is around three times higher than the risk for women.
In Germany, bladder cancer is the fourth most common tumor in men and the twelfth most common in women. Around 16,000 new cases occur in Germany every year.
Chronic inflammation and tobacco consumption are considered to be the main causes of bladder cancer.
Our therapeutic approach.
Chemotherapeutic agents are indispensable for the treatment of tumors. For example, the administration of doxorubicin is recommended for bladder cancer.
The initial treatment should take place within the first 24 hours after the operation if possible. Patients with an increased risk of recurrence are usually followed by intensive treatment over several months.
JEmedis offers a medicine* developed for this purpose with a special application set.
New therapeutics.
JEmedis has set itself the task of providing optimal support for patients and treating physicians. We develop therapy concepts and products for this purpose.
We are not only very proud of this, we also draw inspiration and motivation from it for the development of further preparations.
* For risks and side effects, read the package leaflet and ask your doctor or pharmacist.
Innovative active ingredient development at JEmedis.
JEmedis is developing a further preparation for the prevention of recurrence of superficial bladder cancer. The shortage of active substances that has unfortunately become a regular occurrence in many diseases also affects the treatment of bladder cancer. We are confident that the preparation we are currently developing will make an effective contribution to closing this supply gap.
